Digital mental health company SilverCloud Health is partnering with Microsoft to enhance its...
Microsoft and SilverCloud partner on AI mental health research
Digital mental health company SilverCloud Health is partnering with Microsoft to enhance its product with artificial intelligence (AI).
ESMO 2019: Early colon cancer detection blood test has positive result
Immuno-Transcriptomics firm Novigenix has received positive results from its early colon cancer detection blood test at the European Society for Medical Oncology (ESMO) 2019.
Senseonics completes patient enrolment in PROMISE clinical trial
Medical technology firm Senseonics has completed patient enrolment in the Eversense PROMISE 180-day sensor clinical study of Eversense continuous glucose monitoring (CGM) system in people with diabetes.
Abbott’s AI solution helps detect heart attack in hospitals
A clinical study by Abbott has shown that its artificial intelligence (AI) technology can accurately identify patients having a heart attack in emergency rooms.
AI-powered blood test identifies PTSD in early study
Post-traumatic stress disorder (PTSD) biomarkers have been identified in the blood samples of veterans with 77% accuracy using an artificial intelligence (AI) tool.
Abbott to trial TriClip system to treat tricuspid regurgitation
Abbott has initiated a pivotal investigational device exemption (IDE) trial to evaluate the use of its TriClip transcatheter tricuspid valve repair system to treat severe tricuspid regurgitation (TR).
Self-monitoring app can help manage uncontrolled asthma
A treatment adjustment algorithm based on lung function and symptoms inputted to a mobile app could be an efficient tool in managing uncontrolled asthma, according to a new study.
Success for AstraZeneca’s heart failure therapy Farxiga
AstraZeneca announced the success of its heart failure treatment Farxiga. This trial success could pave the way for a new treatment strategy in HF, helping to fulfil the multiple unmet needs in this area.
Are drug-sparing regimens the next step in HIV management?
Reductions in pill burden and dosing, improvements in safety and tolerability, and increased barriers to resistance have changed HIV management.
Surmodics closes trial enrolment for SurVeil drug-coated balloon
Medical device maker Surmodics has completed patient enrolment for the TRANSCEND clinical trial designed to evaluate its SurVeil drug-coated balloon (DCB).
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.